PTH analogs for renal osteodystrophy and related uses
US7270968B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2001 |
| Grant date | Sep 18, 2007 |
| Priority date | — |
| Expiry date | Nov 24, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2510/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to a mammalian cell lacking type-1 parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) receptor (PTH1R) activity and containing carboxyl-terminal parathyroid hormone receptor (CPTHR) activity. The invention also relates to a method of screening for agonists or antagonists for CPTHR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.